Discovery of a Highly Potent, Nonabsorbable Apical Sodium-Dependent Bile Acid Transporter Inhibitor (GSK2330672) for Treatment of Type 2 Diabetes

Author:

Wu Yulin1,Aquino Christopher J.1,Cowan David J.1,Anderson Don L.1,Ambroso Jeff L.1,Bishop Michael J.1,Boros Eric E.1,Chen Lihong1,Cunningham Alan1,Dobbins Robert L.1,Feldman Paul L.1,Harston Lindsey T.1,Kaldor Istvan W.1,Klein Ryan1,Liang Xi1,McIntyre Maggie S.1,Merrill Christine L.1,Patterson Kristin M.1,Prescott Judith S.1,Ray John S.1,Roller Shane G.1,Yao Xiaozhou1,Young Andrew1,Yuen Josephine1,Collins Jon L.1

Affiliation:

1. GlaxoSmithKline Research & Development, Five Moore Drive, Research Triangle Park, North Carolina 27709, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Reference23 articles.

1. Recent facts about diabetes can be found via the Internet at the World Health Organization website:Diabetes,Fact Sheet no. 312:World Health Organization:Geneva,March, 2013; http://www.who.int/mediacentre/factsheets/fs312/en/.

2. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

3. Incretins and other peptides in the treatment of diabetes

4. The incretin system and its role in type 2 diabetes mellitus

5. The entero-insular axis in type 2 diabetes - incretins as therapeutic agents

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3